Hypertension is one of the major global health problems, often referred to as a silent killer because it typically presents without symptoms but can lead to serious complications, including coagulation disorders. One of the key parameters for assessing coagulation function is clotting time. Uncontrolled hypertension can cause endothelial damage, which accelerates the activation of the coagulation pathway. This study aims to describe the clotting time in hypertensive patients using the slide method in the working area of UPTD Puskesmas Kuala Lempuing, Bengkulu City, in 2025. This research employed a descriptive design with a quantitative approach. A total of 31 respondents were selected using accidental sampling from a population of 100 hypertensive patients. Data were collected through direct measurement of blood pressure and capillary clotting time using the slide method. The data were analyzed univariately. The average age of respondents was 51.8 years, ranging from 35 to 74 years. Nearly all respondents were female (97%). The majority had mild hypertension (68%), nearly a quarter had moderate hypertension (26%), and a small proportion had severe hypertension (6%). The average clotting time was 2 minutes, with a minimum of 1 minute and a maximum of 4 minutes and 30 seconds. The average blood clotting time in individuals with hypertension falls within the lower limit of the normal range, with some respondents experiencing shortened clotting time and a small proportion suffering from severe hypertension. Therefore, regular monitoring of coagulation function is recommended as part of hypertension management.

Clotting Time, Hypertension, Blood, Detection